NOS3 and metabolic dysfunction-associated steatotic liver disease: Moreover, eNOS−/− mice fed a HFD showed a significant elevation of liver fat fraction compared with WT mice fed a HFD (Figure 1d), suggesting a different NAFLD progression profile in this group.